Research
Energy balance
GLP-1 RA use remained low overall for treatment of T2D, particularly among patients with ASCVD.
Clinicians should recognize the need for increased GLP-1 RA prescribing, especially for patients with ASCVD.
StrongSupportsmedium confidence
In this cohort study of US patients with T2D, GLP-1 RA use increased, but remained low overall for treatment of T2D, particularly among patients with ASCVD.
Why this rating
Based on a retrospective cohort analysis of a large patient population.
Source
Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
Lauren A. Eberly et al. · JAMA Health Forum · 2021
DOI 10.1001/jamahealthforum.2021.4182
cohort · n=1180260Cited 259×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →